UK markets closed

REMSleep Holdings, Inc. (RMSL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0105-0.0005 (-4.18%)
At close: 03:59PM EDT

REMSleep Holdings, Inc.

14175 ICOT Boulevard
Suite 300
Clearwater, FL 33760
United States
813 367 3855

IndustryMedical Devices
Full-time employees2

Key executives

NameTitlePayExercisedYear born
Mr. Thomas J. WoodFounder, CEO, President, Secretary & DirectorN/AN/A1946
Mr. Jonathan B. LaneVP & CTON/AN/A1960
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves sleep product distributors, home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Clearwater, Florida.

Corporate governance

REMSleep Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.